The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

Concerns about eventual competition for Allergan Inc.’s cash cow Botox don’t seem to be weighing on the Irvine drug maker’s shares. For now, investors seem content with the company’s strong ...

Last week, Allergan CEO Brent Saunders told investors that Botox “continues to remain very strong” in migraine despite the arrival of three drugs from the brand-new CGRP class. But exactly how strong?

With CGRP drugs on the rise in the preventive migraine market, old stalwarts like Allergan's Botox are feeling the pinch from the new competition. But a new survey says neurologists may not be so ...

“We sit in the low 60s in terms of Botox share, and that's a clear leadership position by a large margin in the U.S.,” AbbVie ...

Shares of Irvine-based Allergan Inc. jumped Monday as Wall Street got its first crack at the stock after word Friday that the company’s flagship Botox drug was approved as a treatment for migraine ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

Drugmaker AbbVie said Tuesday it would buy Botox maker Allergan for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster ...

Jenny Mollen helps kick off National BOTOX® Cosmetic Day. DUBLIN, Nov. 18, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), the maker of BOTOX ® Cosmetic, has announced the first-ever National BOTOX ® ...

IRVINE, Calif., Nov. 16, 2020 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its second annual BOTOX® Cosmetic Day on Wednesday, November 18, 2020. The event is ...

When the maker of the top-selling arthritis drug says it’s buying a leader in anti-wrinkle treatments, you’d be forgiven if your initial response to the news was that it seems like a match made in ...

For the second time in less than a year, the Food and Drug Administration has warned Irvine-based Allergan Inc. that advertisements for its anti-wrinkle drug Botox are misleading and should be pulled.